Your browser doesn't support javascript.
loading
In Silico Structure-Based Vaccine Design.
Piplani, Sakshi; Winkler, David; Honda-Okubo, Yoshikazu; Khanna, Varun; Petrovsky, Nikolai.
Afiliação
  • Piplani S; Vaxine Pty Ltd, Adelaide, SA, Australia.
  • Winkler D; School of Pharmacy, University of Nottingham, Nottingham, UK.
  • Honda-Okubo Y; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia.
  • Khanna V; Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC, Australia.
  • Petrovsky N; Vaxine Pty Ltd, Adelaide, SA, Australia.
Methods Mol Biol ; 2673: 371-399, 2023.
Article em En | MEDLINE | ID: mdl-37258928
Structure-based vaccine design (SBVD) is an important technique in computational vaccine design that uses structural information on a targeted protein to design novel vaccine candidates. This increasing ability to rapidly model structural information on proteins and antibodies has provided the scientific community with many new vaccine targets and novel opportunities for future vaccine discovery. This chapter provides a comprehensive overview of the status of in silico SBVD and discusses the current challenges and limitations. Key strategies in the field of SBVD are exemplified by a case study on design of COVID-19 vaccines targeting SARS-CoV-2 spike protein.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article